Ro4938581 is actually a nootropic drug invented in 2009 by a crew Operating for Hoffmann-La Roche, which functions for a subtype-selective inverse agonist within the ?5 subtype on the benzodiazepine binding web page to the GABAA receptor. It has great selectivity with the ?five subtype and did not generate convulsant or anxiogenic effects in animal